CIK 0001501697
- Non-accelerated filer
- Smaller reporting company
X4 Pharmaceuticals, Inc
Sign in to watch- Ticker
- XFOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 273181608
- Phone
- +1 857-529-8300
- Business address
- 61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
- Former names
- Arsanis, Inc.
- Open-market buys, last 90 days
- $11,884
- in 1 filing
- Open-market sales, last 90 days
- $33,658
- in 1 filing
Net −$21,775. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-01-05 | Ragan Paula President and CEO | Sale | −2,400 | $7.00 | $17K | 277,723 |
| 2020-12-31 | Cadavid Diego Chief Medical Officer | Grant or award · Stock Option (right to buy) | +121,500 | $6.43 | $781K | 121,500 |
| 2020-12-23 | Ragan Paula President and CEO | Sale | −4,800 | $7.00 | $34K | 280,123 |
| 2020-11-30 | Taveras Arthur Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +121,150 | $6.60 | $800K | 121,150 |
| 2020-10-20 | Stewart Murray Director | Grant or award · Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2020-10-05 | Ragan Paula President and CEO | Sale | −1,797 | $7.00 | $13K | 284,923 |
| 2020-10-05 | Lawton Alison Frances Director | Grant or award · Stock Option (right to buy) | +6,854 | 6,854 | ||
| 2020-10-05 | Bridger Gary Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2020-10-02 | Ragan Paula President and CEO | Sale | −603 | $7.00 | $4K | 286,720 |
| 2020-09-21 | Mostafa Adam S. Chief Financial Officer | Sale | −10,834 | $7.08 | $77K | 29,589 |
| 2020-09-09 | Skerlj Renato Chief Scientific Officer | Sale | −5,834 | $8.05 | $47K | 42,076 |
| 2020-09-09 | Ragan Paula President and CEO | Sale | −8,840 | $8.04 | $71K | 287,323 |
| 2020-09-09 | Meisner Derek M General Counsel | Sale | −8,334 | $8.05 | $67K | 16,666 |
| 2020-09-02 | Ragan Paula President and CEO | Sale | −2,400 | $7.99 | $19K | 296,163 |
| 2020-08-17 | Mostafa Adam S. Chief Financial Officer | Grant or award | +16,250 | 40,423 | ||
| 2020-08-17 | Skerlj Renato Chief Scientific Officer | Grant or award | +8,750 | 47,910 | ||
| 2020-08-17 | Ragan Paula President and CEO | Grant or award | +44,825 | 298,563 | ||
| 2020-08-17 | Meisner Derek M General Counsel | Grant or award | +12,500 | 25,000 | ||
| 2020-08-14 | Mostafa Adam S. Chief Financial Officer | Grant or award | +16,250 | 24,173 | ||
| 2020-08-14 | Skerlj Renato Chief Scientific Officer | Grant or award | +8,750 | 39,160 |
Page 11 of 25 · 490 trades